Table 2. Summarised results of EORTC evaluation example.

	SUVmax baseline	SUVmax follow up
Liver target 1	14.76	16.24
Liver target 2	16.41	16.31
Lymph node target 1	10.0	0 (disappeared)
Breast tumor target 1	10.75	10.09
Bone target 1	9.91	10.67
ΣSUVmax target lesions	61.83	53.31
ΔΣSUVmax target lesions	-13%

ΣSUVmax: Sum of SUVmax

ΔΣSUVmax: Variation (in percentage) of Sum of SUVmax between baseline and follow- up PET